Medica 2026
Nov 16-19, 2026 - Düsseldorf, Germany

tRNA Modifications Detection

Transfer RNA (tRNA) is the key adaptor molecule in protein synthesis. The modifications of tRNA are essential for proper folding, stability, and accurate decoding of genetic information during translation. To date, ~170 RNA modifications discovered in RNAs, about half of which are present in tRNAs. Abnormalities in these modifications have been linked to a variety of diseases, highlighting the importance of reliable analysis techniques. The techniques for analyzing tRNA modifications often face challenges in specificity, sensitivity, and scalability. The Antibody-based analysis offer a promising choice, providing specificity and sensitivity for identifying specific tRNA modifications.

Types of tRNA Modifications

Schematic representation of human cytoplasmic tRNA modifications and their writer enzymesFig. 1 Schematic representation of human cytoplasmic tRNA modifications and their writer enzymes.
(Zhang M, Lu Z. RNA Biol. 2025)

The common modifications can be broadly classified based on their chemical nature:

Methylation: This is the most prevalent type of tRNA modification, involving the addition of a methyl group (CH3) to a nucleotide base or ribose sugar.

Thiolation: Involving the replacement of an oxygen atom with a sulfur atom in a nucleotide base.

Pseudouridylation: Isomerization of uridine to pseudouridine (Ψ), impacting tRNA folding and stability.

Dihydrouridylation: Reduction of uridine to dihydrouridine (D), often found in the D-loop of tRNAs, contributing to tRNA flexibility.

Acetylation: Addition of an acetyl group (COCH3), for example, acetylation of cytidine at position 12 in tRNA, which can influence tRNA recognition by aminoacyl-tRNA synthetases.

Biological Significance of tRNA Modifications

Post-transcriptional modifications of tRNA nucleosides are ubiquitous and occur at specific nucleotide positions. These modifications play several critical roles in some processes.

tRNA modifications and biological processesFig. 2 tRNA modifications and biological processes.
(Cui W.; et al. Int J Biol Sci. 2023)

Structural Stability: Modifications such as pseudouridine (Ψ) and 5-methylcytosine (m5C) enhance the structural integrity of tRNA, promoting correct folding and thermal stability.

Decoding Accuracy: Modifications in the anticodon loop, like inosine (I) and queuosine (Q), improve codon-anticodon interactions, reducing misincorporation of amino acids and ensuring translational fidelity.

Regulation of Gene Expression: Dynamic modulation of tRNA modifications can adjust translation rates in response to cellular signals and stress conditions, affecting protein synthesis globally or selectively.

Adaptation to Environmental Stress: Certain modifications enable organisms to adapt to changes in temperature, nutrient availability, and other environmental factors by altering tRNA function.

Disease Implications

Defects in tRNA modifications, known as "RNA modopathies," lead to pathological effects in a wide range of tissues and cell types. These abnormal modifications can destabilize tRNA molecules, disrupting normal protein translation and contributing to the onset of various diseases, including cancer, neurological disorders, diabetes, and mitochondrial diseases.

tRNA modificationsDiseases
m7GGlioblastoma multiforme, Liposarcoma, Melanoma, Acute myeloIntellectual Disabilities leukemia, Intrahepatic cholangiocarcinoma, hepatocellular carcinoma, Cervical cancer, etc.
m5COvarian cancer, Intellectual Disabilities, depression-like behavior, Dubowitz-like syndrome, etc.
m6AGlioblastoma multiforme, Pancreatic cancer
m3CDevelopmental delay and early-onset epileptic encephalopathy
m1ACervical cancer, Prostate cancer, Hepatocellular carcinoma, Bladder cancer, Glioblastoma multiforme, Alzheimer's disease, Mitochondrial disorders
m1GChildhood diabetes
PSUGlioblastoma multiforme, Neurodevelopmental disorder, Mental disorder, Amyotrophic lateral sclerosis, MLASA
mcm5U34/mcm5s2U34Bladder cancer, Breast cancer, Ovarian cancer, Colon cancer, Melanoma
ac4CSyndromic intellectual disability
ms2t6A37Type 2 diabetes
τm5UMELAS

Detection technologies for tRNA modifications

The importance of tRNA modifications for tRNA function necessitates adequate methods to reliably determine tRNA modifications in complex samples. This has been a focus of active research and development in recent years. Techniques that have emerged include liquid chromatography coupled with mass spectrometry (LC-MS), antibody-based immunoassays, and methodologies that utilize reverse transcription followed by next-generation sequencing (RT-NGS). However, LC-MS and NGS often require extensive sample processing, which can compromise RNA integrity and obscure the structural context essential for understanding functional implications. Antibody-based analysis may offer a promising alternative. By harnessing the high specificity and affinity of antibodies toward particular modified nucleosides, researchers can achieve quantification of tRNA modifications within complex biological samples. Antibodies can be employed in various assay formats, including immunoprecipitations (IP), and immunofluorescence (IF) and dot blot. These techniques often require minimal sample preparation, preserving the native structure of tRNAs and allowing for the exploration of modifications in their physiological context.

Schemes for quantifying RNA modificationsFig. 3 Schemes of RNA modification quantification methods.
(Zhang Y.; et al. Exp Mol Med. 2022)

Product Performance

Creative Diagnostics offers a range of highly validated antibodies for tRNA modifications detection. These antibodies have been thoroughly validated in many immunological applications. Please check out our highly sensitive and specific antibodies in the product list.

DMABC-JX060 m5C Rabbit mAb DotFig. 4 Dot blot analysis of 5-hmC, 5mC and unmodified adenosine using m5C (RNA) Rabbit mAb (Cat. No. DMABC-JX060)

CABT-CS610 m6A Rabbit mAb IFFig. 5 Immunofluorescence analysis of U2OS cells pre-treated with BrdU (subjected UVC irradiation incubated at 37 °C) using m6A Rabbit mAb. (Cat. No. CABT-CS610)

DMABB-JX352 Cm Rabbit mAb DotFig. 6 Dot Blot analysis of 2'-O-methylcytidine and unmodified cytidine using Cm Rabbit mAb (Cat. No. DMABB-JX352)

DPABC-JX034 m6A Rabbit mAb IPFig. 7 RNA Immunoprecipitation analysis of 100 µg mouse liver total RNA ,using m6A Rabbit mAb. (Cat. No. DPABC-JX034)

References

  1. Cui W.; et al. tRNA Modifications and Modifying Enzymes in Disease, the Potential Therapeutic Targets. Int J Biol Sci. 2023 Feb 13;19(4):1146-1162.
  2. Zhang M, Lu Z. tRNA modifications: greasing the wheels of translation and beyond. RNA Biol. 2025 Dec;22(1):1-25.
  3. Zhang Y.; et al. Detection technologies for RNA modifications. Exp Mol Med. 2022 Oct;54(10):1601-1616.
  4. Wu D.; et al. tRNA modifications and tRNA-derived small RNAs: new insights of tRNA in human disease. Cell Biol Toxicol. 2024 Sep 14;40(1):76.
<
tRNA Modifications Related Antibodies

m1A Antibodies

m6,6A Antibodies

m6,6A Antibodies
Cat. No.Product NameApplication
DPABB-JX04Rabbit Anti-N6N6-dimethyladenosine / m6,6A polyclonal antibodyDot, RIPInquiry

m8A Antibodies

m8A Antibodies
Cat. No.Product NameApplication
DMABC-JX075Rabbit Anti-8-methyladenosine (m8A) monoclonal antibody, clone 236-2ELISA, IPInquiry

m4C Antibodies

m4C Antibodies
Cat. No.Product NameApplication
DPABB-JX163Rabbit Anti-N4-Methylcytidine?polyclonal antibodyELISA, WBInquiry
DMABC-JX074Rabbit Anti-N4-methylcytidine (m4C) monoclonal antibody, clone 219IP, ELISAInquiry

m1I Antibodies

m1I Antibodies
Cat. No.Product NameApplication
DPABB-JX03Rabbit Anti-1-methylinosine polyclonal antibodyDotInquiry

m1G Antibodies

m1G Antibodies
Cat. No.Product NameApplication
DMABC-JX076Rabbit Anti-1-methylguanosine (m1G)) monoclonal antibody, clone 261Dot, IP, ELISAInquiry

m3G Antibodies

m3G Antibodies
Cat. No.Product NameApplication
DMABB-JX52Mouse Anti-2,2,7-trimethylguanosine?monoclonal antibody, clone 340IF, IPInquiry

m7G Antibodies

m7G Antibodies
Cat. No.Product NameApplication
DMABC-JX059Mouse Anti-7-Methylguanosine (m7G) monoclonal antibody, clone 4F21IHC, Dot, ELISAInquiry

m2,2G Antibodies

m2,2G Antibodies
Cat. No.Product NameApplication
DMABC-JX072Rabbit Anti-N2,N2-dimethylguanosine (m2,2G) monoclonal antibody, clone 51Dot, IP, ELISAInquiry

Ψ Antibodies

ac4C Antibodies

ac4C Antibodies
Cat. No.Product NameApplication
DPABC-JX034Rabbit Anti-N4-acetylcytidine (ac4C) polyclonal antibodyDot, ELISAInquiry

Inosine Antibodies

Inosine Antibodies
Cat. No.Product NameApplication
DMABB-JX53Mouse Anti-Inosine monoclonal antibody, clone 362RIPInquiry
Inquiry Basket
loading Loading ......

Inquiry

Inquiry